Figure 1From: Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature reviewLocal guidelines for recombinant activated factor VII (rFVIIa) use to control refractory hemorrhage in patients with extracorporeal membrane oxygenation.Back to article page